Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Association of prior antiplatelet agents with mortality in sepsis patients.

Literature DB >> 26873835

Association of prior antiplatelet agents with mortality in sepsis patients.

Min-Juei Tsai^1,2, Chia-Jen Shih^2,3, Yung-Tai Chen^4,5.

Abstract

Entities: Disease Species

Mesh：

Substances：

Year: 2016 PMID： 26873835 DOI： 10.1007/s00134-016-4230-x

Source DB: PubMed Journal: Intensive Care Med ISSN： 0342-4642 Impact factor: 17.440

× No keyword cloud information.

18 in total

1. Onset and offset of platelet inhibition after high-dose clopidogrel loading and standard daily therapy measured by a point-of-care assay in healthy volunteers.

Authors: Matthew J Price; Jacqueline L Coleman; Steven R Steinhubl; Garrett B Wong; Christopher P Cannon; Paul S Teirstein
Journal: Am J Cardiol Date: 2006-07-07 Impact factor: 2.778

2. Association of prior antiplatelet agents with mortality in sepsis patients: a nationwide population-based cohort study.

Authors: Min-Juei Tsai; Shuo-Ming Ou; Chia-Jen Shih; Pei-Wen Chao; Lan-Fu Wang; Yu-Ning Shih; Szu-Yuan Li; Shu-Chen Kuo; Yen-Tao Hsu; Yung-Tai Chen
Journal: Intensive Care Med Date: 2015-04-01 Impact factor: 17.440

3. Acetyl salicylic acid usage and mortality in critically ill patients with the systemic inflammatory response syndrome and sepsis.

Authors: Damon P Eisen; David Reid; Emma S McBryde
Journal: Crit Care Med Date: 2012-06 Impact factor: 7.598

4. Effects of low-dose acetylsalicylic acid and atherosclerotic vascular diseases on the outcome in patients with severe sepsis or septic shock.

Authors: Gordon Philipp Otto; Maik Sossdorf; Janina Boettel; Björn Kabisch; Hannes Breuel; Johannes Winning; Wolfgang Lösche
Journal: Platelets Date: 2012-09-20 Impact factor: 3.862

5. Prehospital aspirin use is associated with reduced risk of acute respiratory distress syndrome in critically ill patients: a propensity-adjusted analysis.

Authors: Wei Chen; David R Janz; Julie A Bastarache; Addison K May; Hollis R O'Neal; Gordon R Bernard; Lorraine B Ware
Journal: Crit Care Med Date: 2015-04 Impact factor: 7.598

6. Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome.

Authors: Hollis R O'Neal; Tatsuki Koyama; Elizabeth A S Koehler; Edward Siew; Blake R Curtis; Richard D Fremont; Addison K May; Gordon R Bernard; Lorraine B Ware
Journal: Crit Care Med Date: 2011-06 Impact factor: 7.598

Association of prior antiplatelet agents with mortality in sepsis patients.

1. Onset and offset of platelet inhibition after high-dose clopidogrel loading and standard daily therapy measured by a point-of-care assay in healthy volunteers.

2. Association of prior antiplatelet agents with mortality in sepsis patients: a nationwide population-based cohort study.

3. Acetyl salicylic acid usage and mortality in critically ill patients with the systemic inflammatory response syndrome and sepsis.

4. Effects of low-dose acetylsalicylic acid and atherosclerotic vascular diseases on the outcome in patients with severe sepsis or septic shock.

5. Prehospital aspirin use is associated with reduced risk of acute respiratory distress syndrome in critically ill patients: a propensity-adjusted analysis.

6. Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome.

7. 15-epi-lipoxin A4 inhibits myeloperoxidase signaling and enhances resolution of acute lung injury.

8. Aspirin inhibits nuclear factor-kappa B mobilization and monocyte adhesion in stimulated human endothelial cells.

9. Benefit of low-dose aspirin and non-steroidal anti-inflammatory drugs in septic patients.

10. Outcomes of severe sepsis and septic shock patients on chronic antiplatelet treatment: a historical cohort study.

1. Dynamic changes in human single-cell transcriptional signatures during fatal sepsis.

2. Targeting Gα₁₃-integrin interaction ameliorates systemic inflammation.